These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19581607)

  • 1. Charter challenge of ban on direct-to-consumer advertising to be heard by Ontario court in mid-June.
    Silversides A
    CMAJ; 2009 Jul; 181(1-2):E5-6. PubMed ID: 19581607
    [No Abstract]   [Full Text] [Related]  

  • 2. The European pharmaceutical industry: coming to a screen near you?
    Rutter P; Gilbody S
    J R Soc Med; 2008 Oct; 101(10):485-8. PubMed ID: 18840863
    [No Abstract]   [Full Text] [Related]  

  • 3. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
    Schwartz MI
    Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
    [No Abstract]   [Full Text] [Related]  

  • 4. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
    Greene JA; Watkins ES
    N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
    [No Abstract]   [Full Text] [Related]  

  • 5. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.
    Frosch DL; Grande D; Tarn DM; Kravitz RL
    Am J Public Health; 2010 Jan; 100(1):24-32. PubMed ID: 19910354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reforming direct-to-consumer advertising.
    Liang BA; Mackey T
    Nat Biotechnol; 2011 May; 29(5):397-400. PubMed ID: 21552236
    [No Abstract]   [Full Text] [Related]  

  • 7. Time for New Zealand to ban direct-to-consumer advertising of prescription medicines.
    Menkes DB; Mintzes B; Lexchin J
    N Z Med J; 2023 May; 136(1575):7-9. PubMed ID: 37167935
    [No Abstract]   [Full Text] [Related]  

  • 8. The Future of Drug-Pricing Transparency.
    Feldman WB; Rome BN; Avorn J; Kesselheim AS
    N Engl J Med; 2021 Feb; 384(6):489-491. PubMed ID: 33440087
    [No Abstract]   [Full Text] [Related]  

  • 9. A decade of direct-to-consumer advertising of prescription drugs.
    Donohue JM; Cevasco M; Rosenthal MB
    N Engl J Med; 2007 Aug; 357(7):673-81. PubMed ID: 17699817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striving for quality use of medicines: how effective is Australia's ban on direct-to-consumer prescription medicine advertising?
    Brown S
    J Law Med; 2009 Feb; 16(4):666-83. PubMed ID: 19297873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER
    N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct-to-consumer advertising under fire.
    Bull World Health Organ; 2009 Aug; 87(8):576-7. PubMed ID: 19705005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
    Toop L; Richards D; Saunders B
    N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
    [No Abstract]   [Full Text] [Related]  

  • 14. EU health ministers reject proposal for limited direct to consumer advertising.
    Watson R
    BMJ; 2003 Jun; 326(7402):1284. PubMed ID: 12805139
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct to consumer advertisement: The world of the market place.
    Howell JV
    BMJ; 2007 Oct; 335(7622):683-4. PubMed ID: 17916818
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct-to-consumer advertising of prescription drugs: European Commission persists in putting industry's interests first.
    Prescrire Int; 2013 Jan; 22(134):24-5, 27. PubMed ID: 23373084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.
    Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E
    Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 20. Is banning direct to consumer advertising of prescription medicine justified paternalism?
    Lau Y
    J Bioeth Inq; 2005; 2(2):69-74. PubMed ID: 16317865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.